Steele, J P <br/><br/>
Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2001 
 - 497-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1023/a:1011139918558  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Drug Delivery Systems<br/>Female<br/>Humans<br/>Liposomes<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Pleural Neoplasms--drug therapy<br/>Survival Rate